key: cord-0747341-6gu5p44y
authors: Desingu, Perumal A.; Nagarajan, K.
title: Omicron BA.2 lineage spreads in clusters and is concentrated in Denmark
date: 2022-02-21
journal: J Med Virol
DOI: 10.1002/jmv.27659
sha: 57b3a68613e64defd1f7569972529fed9e5a847c
doc_id: 747341
cord_uid: 6gu5p44y

The Omicron variant has recently become a dominant variant globally with four lineages such as BA.1, BA.2, BA.3, and B.1.1.529. But little is known about which parts of the world the BA.2 lineage dominates. Here we find out that BA.2 has its central cluster of infection installed in Denmark. It should be noted that 79.4%% of the total BA.2 sequences belong to Denmark (as of January 18, 2022). The BA.2 lineage phylogenetically consists of five groups: Sweden/Denmark, Philippines, Hong Kong, India, and China. The ORF3a protein of BA.2, which is spreading in Denmark, contains a specific mutation called H78Y, and this mutation is not widely found in other countries. The Philippines, Hong Kong, India, and China groups of BA.2 also have their own unique mutations. A future experimental study is warranted to understand the significance of these mutations to reveal why this lineage is widely spreading in Denmark, which we hope will help design antiviral and antibodies to control the spread of BA.2 lineage in Denmark and other countries. This article is protected by copyright. All rights reserved.

BA.2 also have their own unique mutations. A future experimental study is warranted to understand the significance of these mutations to reveal why this lineage is widely spreading in Denmark, which we hope will help design antiviral and antibodies to control the spread of BA.2 lineage in Denmark and other countries.

The Omicron variant, first detected in Africa in November 2021, has spread to six continents in just 2 months, affecting more than 150 countries/territories. 1 Therefore, it can be believed that these two nucleotide mutations do not cause any change in the functional state of the protein. However, these nucleotide mutations can be expected to cause some effect when designing PCR primers/probes in this specific region.

Next, we explore whether any subgroups within the BA.2 lineage extend specifically to geographical locations. In this analysis, we considered that there are five subgroups within the BA.2 lineage, and they are subdivided into geographical areas, namely Sweden/Denmark, Philippines, Hong Kong, India, and China ( Figure 1E ). Of these, we note that the Philippines and Hong Kong subgroups differ significantly from other sub-groups ( Figure 1E ). Also, these Philippines (Figure 2A,B) . ORF1a: A2909V is a mutation in nonstructural proteins 4 (Nsp4); although no experimental studies have been performed on the functional significance of this specific mutation, it is well-known that Nsp4 is a protein required for virus replication. 5, 6 Similarly, no experimental studies have been performed on the functional significance of ORF3a: L140F mutation, although it is essential to note that ORF3 is a protein that contributes to the viral release of viral ion channels (viroporins). 7 Then we noticed that in India, subgroup (BA.2) has unique mutations of ORF1a: -3677L, ORF1b: S959P, and ORF7b: H42Y ( Figure 1E) have been performed on the functional significance of these specific mutations; it is well-known that Nsp6 is the protein required for virus replication 5,6 and the Nsp13 helicase protein. 8, 9 Finally, we note that there is a unique mutation in the Sweden/ Denmark sub-group called ORF3a: H78Y ( Figure 1E 

Enhancing response to Omicron SARS-CoV-2 variant: Technical brief and priority actions for Member States

Mutational and phylogenetic analyses of the two lineages of the Omicron variant

Emergence of Omicron third lineage BA.3 and its importance

Structural characterization of SARS-CoV-2: where we are, and where we need to be

Mapping the nonstructural transmembrane proteins of severe acute respiratory syndrome coronavirus 2

Unification and extensive diversification of M/Orf3-related ion channel proteins in coronaviruses and other nidoviruses

Discovery of COVID-19 inhibitors targeting the SARS-CoV-2 Nsp13 Helicase

Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase